Erytech Pharma S.A. ERYTECH Provides Business Update and Reports Financial Results for First Quarter 2019

Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for First Quarter 2019

15:41 EDT 6 May 2019 | FinanzNachrichten

Conference call and webcast on Tuesday, May 7 at 2:30 pm CET/8:30 am EDTTRYbeCA1, pivotal Phase 3 trial for eryaspase in second line pancreatic cancer, actively enrolling patientsConstruction of ne...

More From BioPortfolio on "Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for First Quarter 2019"